Brief: Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in 6 Latin American Countries for INBRIJA Approval
06/11/2023 13:08
Nov 6 (Reuters) - Acorda Therapeutics Inc ACOR.O :
* ACORDA THERAPEUTICS INC: ANNOUNCES BIOPAS LABORATORIES
SUBMISSION TO REGULATORY AGENCIES IN SIX LATIN AMERICAN
COUNTRIES FOR APPROVAL OF INBRIJA
* ACORDA THERAPEUTICS: BIOPAS EXPECTS TO SUBMIT ADDITIONAL
REGULATORY FILINGS FOR APPROVAL OF INBRIJA IN CHILE IN LATE 2023
& IN MEXICO & BRAZIL IN 2024
Source text for Eikon: ID:nBw1XsRNQa
Further company coverage: ACOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acorda Therapeutics
See all newsBrief: Acorda TherapeuticsCourt Held Hearing To Consider Approval Of Sale Of Substantially All Of Co's Assets To Merz Pharmaceuticals Under Asset Sale
Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings
Live Markets: Biotech companies in 'Darwinian' world as cash remains king
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease (updated)
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease